These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6824376)

  • 1. Therapeutic benefits of 5-hydroxytryptamine inhibition following pulmonary embolism.
    Huval WV; Mathieson MA; Stemp LI; Dunham BM; Jones AG; Shepro D; Hechtman HB
    Ann Surg; 1983 Feb; 197(2):220-5. PubMed ID: 6824376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of serotonin in patients with acute respiratory failure.
    Huval WV; Lelcuk S; Shepro D; Hechtman HB
    Ann Surg; 1984 Aug; 200(2):166-72. PubMed ID: 6547816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of serotonin on the cardiopulmonary circulatory system with and without 5-HT2-receptor blockade by ketanserin.
    Breuer J; Meschig R; Breuer HW; Arnold G
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S64-6. PubMed ID: 2412062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thromboxane mediation of cardiopulmonary effects of embolism.
    Utsonomiya T; Krausz MM; Levine L; Shepro D; Hechtman HB
    J Clin Invest; 1982 Aug; 70(2):361-8. PubMed ID: 6284801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of 5-HT2 receptor inhibition in pulmonary embolization.
    Thompson JA; Millen JE; Glauser FL; Hess ML
    Circ Shock; 1986; 20(4):299-309. PubMed ID: 3791578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of vasodilators on canine cardiopulmonary function when a decrease in cardiac output complicates an increase in right ventricular afterload.
    Ghignone M; Girling L; Prewitt RM
    Am Rev Respir Dis; 1985 Apr; 131(4):527-30. PubMed ID: 3994147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiopulmonary effects of ketanserin infusion in human pulmonary embolism.
    Huet Y; Brun-Buisson C; Lemaire F; Teisseire B; Lhoste F; Rapin M
    Am Rev Respir Dis; 1987 Jan; 135(1):114-7. PubMed ID: 3800140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of serotonin inhibition in air embolism in dogs.
    Vincent JL; Goldstein J; Domb M; Lignan H
    Eur Surg Res; 1988; 20(3):175-80. PubMed ID: 3402512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonin receptor blockade improves cardiac output and hypoxia in porcine ARDS.
    Sielaff TD; Kellum JM; Sugerman HJ; Kuemmerle JF; Tatum JL
    J Surg Res; 1987 Aug; 43(2):118-27. PubMed ID: 3626534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-HT2-receptor blockade in the treatment of heart failure. A preliminary study.
    Demoulin JC; Bertholet M; Soumagne D; David JL; Kulbertus HE
    Lancet; 1981 May; 1(8231):1186-8. PubMed ID: 6112531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ketanserin prevents platelet aggregation and endotoxin-induced pulmonary vasoconstriction.
    Meuleman TR; Hill DC; Port JD; Stanley TH; Pace NL; Mohammad SF
    Crit Care Med; 1983 Aug; 11(8):606-11. PubMed ID: 6872549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ketanserin, a serotonin antagonist. Administration in patients with acute respiratory failure.
    Vincent JL; Degaute JP; Domb M; Simon P; Berre J; Vandesteene A
    Chest; 1984 Apr; 85(4):510-3. PubMed ID: 6705581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of increased lung serotonin levels to endotoxin-induced pulmonary hypertension in sheep. Effect of a serotonin antagonist.
    Demling RH; Wong C; Fox R; Hechtman H; Huval W
    Am Rev Respir Dis; 1985 Dec; 132(6):1257-61. PubMed ID: 2934013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noncardiogenic pulmonary edema after abdominal aortic aneurysm surgery.
    Paterson IS; Klausner JM; Pugatch R; Allen P; Mannick JA; Shepro D; Hechtman HB
    Ann Surg; 1989 Feb; 209(2):231-6. PubMed ID: 2916866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet-vessel wall interactions: implication of 5-hydroxytryptamine. A review.
    De Clerck F; van Nueten JM; Reneman RS
    Agents Actions; 1984 Dec; 15(5-6):612-26. PubMed ID: 6397984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haemodynamic effects of ketanserin either alone or with oxygen in COPD patients with secondary pulmonary hypertension.
    Domenighetti G; Leuenberger P; Feihl F
    Monaldi Arch Chest Dis; 1997 Oct; 52(5):429-33. PubMed ID: 9510660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tryptaminergic receptors in the bovine pulmonary vasculature: effects of ketanserin.
    Ogunbiyi PO; Eyre P
    Res Commun Chem Pathol Pharmacol; 1984 Apr; 44(1):31-55. PubMed ID: 6328601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of 5-hydroxytryptamine inhibition on gas exchange and pulmonary hemodynamics in acute canine pulmonary embolism.
    Kawai A; Umeda A; Mori M; Takasugi T; Yamaguchi K; Kawashiro T
    Adv Exp Med Biol; 1994; 345():75-82. PubMed ID: 8079783
    [No Abstract]   [Full Text] [Related]  

  • 19. Pulmonary vascular pressure-flow characteristics. Effects of dopamine before and after pulmonary embolism.
    Ducas J; Stitz M; Gu S; Schick U; Prewitt RM
    Am Rev Respir Dis; 1992 Aug; 146(2):307-12. PubMed ID: 1489117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular effects of ketanserin in closed-chest anesthetized dogs.
    van de Water A; Wouters L; Xhonneux R; Reneman S
    Arch Int Pharmacodyn Ther; 1985 Jun; 275(2):267-78. PubMed ID: 3161481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.